143 related articles for article (PubMed ID: 6806420)
1. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate.
Acs Z; Antoni FA; Makara GB
J Endocrinol; 1982 May; 93(2):239-45. PubMed ID: 6806420
[TBL] [Abstract][Full Text] [Related]
2. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence.
Bloch B; Ling N; Benoit R; Wehrenberg WB; Guillemin R
Nature; 1984 Jan 19-25; 307(5948):272-3. PubMed ID: 6420704
[TBL] [Abstract][Full Text] [Related]
3. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
Maiter D; Underwood LE; Martin JB; Koenig JI
Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
[TBL] [Abstract][Full Text] [Related]
4. Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats.
Corder R; Saudan P; Mazlan M; McLean C; Gaillard RC
Neuroendocrinology; 1990 Jan; 51(1):85-92. PubMed ID: 2106092
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.
Meister B; Ceccatelli S; Hökfelt T; Andén NE; Andén M; Theodorsson E
Exp Brain Res; 1989; 76(2):343-68. PubMed ID: 2569986
[TBL] [Abstract][Full Text] [Related]
6. Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation.
Spinedi E; Johnston C; Negro-Vilar A
Endocrinology; 1984 Jul; 115(1):267-72. PubMed ID: 6145582
[TBL] [Abstract][Full Text] [Related]
7. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats.
Wakabayashi I; Hatano H; Minami S; Tonegawa Y; Akira S; Sugihara H; Ling NC
Brain Res; 1986 May; 372(2):361-5. PubMed ID: 3085872
[TBL] [Abstract][Full Text] [Related]
8. The hypothalamo-infundibular growth hormone-releasing hormone (GH-RH) system of the rat.
Merchenthaler I; Csontos C; Kallo I; Arimura A
Brain Res; 1986 Jul; 378(2):297-302. PubMed ID: 3089538
[TBL] [Abstract][Full Text] [Related]
9. Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat.
Dolnikoff MS; Kater CE; Egami M; de Andrade IS; Marmo MR
Neuroendocrinology; 1988 Dec; 48(6):645-9. PubMed ID: 3251163
[TBL] [Abstract][Full Text] [Related]
10. Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axis.
Larsen PJ; Mikkelsen JD; Jessop D; Lightman SL; Chowdrey HS
J Endocrinol; 1994 Jun; 141(3):497-503. PubMed ID: 8071649
[TBL] [Abstract][Full Text] [Related]
11. Effects of naloxone and neonatal treatment with monosodium-L-glutamate on growth hormone and prolactin release induced by electrical stimulation of the medial-basal hypothalamus in rats.
Antoni FA; Kanyicska B; Makara GB
J Endocrinol; 1983 Mar; 96(3):427-32. PubMed ID: 6833931
[TBL] [Abstract][Full Text] [Related]
12. Neonatal monosodium glutamate treatment alters the response of median eminence luteinizing hormone-releasing hormone nerve terminals to potassium and prostaglandin E2.
DePaolo LV; Negro-Vilar A
Endocrinology; 1982 Mar; 110(3):835-41. PubMed ID: 7035149
[No Abstract] [Full Text] [Related]
13. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
Bodnar RJ; Truesdell LS; Nilaver G
Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
[TBL] [Abstract][Full Text] [Related]
14. Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat.
Zoli M; Ferraguti F; Biagini G; Cintra A; Fuxe K; Agnati LF
Neurosci Lett; 1991 Nov; 132(2):225-8. PubMed ID: 1686076
[TBL] [Abstract][Full Text] [Related]
15. Neonatal treatment with monosodium-L-glutamate: differential effects on growth hormone and prolactin release induced by morphine.
Antoni FA; Kanyicska B; Mezey E; Makara GB
Neuroendocrinology; 1982 Oct; 35(4):231-5. PubMed ID: 7145019
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the central nervous system-pituitary-adrenal axis in rats after neonatal treatment with monosodium glutamate.
Magariños AM; Estivariz F; Morado MI; De Nicola AF
Neuroendocrinology; 1988 Aug; 48(2):105-11. PubMed ID: 2851747
[TBL] [Abstract][Full Text] [Related]
17. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor.
Millard WJ; Martin JB; Audet J; Sagar SM; Martin JB
Endocrinology; 1982 Feb; 110(2):540-50. PubMed ID: 6120072
[TBL] [Abstract][Full Text] [Related]
18. Changes in corticotrophin releasing factor of the stalk median eminence in rats with various cuts around the medial basal hypothalamus.
Makara GB; Stark E; Rappay G; Kárteszi M; Palkovits M
J Endocrinol; 1979 Nov; 83(2):165-73. PubMed ID: 316445
[TBL] [Abstract][Full Text] [Related]
19. Monosodium glutamate lesions in rat hypothalamus studied by immunohistochemistry for gonadotropin releasing hormone, neurotensin, tyrosine hydroxylase, and glutamic acid decarboxylase and by autoradiography for [3H] estradiol.
Jennes L; Stumpf WE; Bissette G; Nemeroff CB
Brain Res; 1984 Aug; 308(2):245-53. PubMed ID: 6148123
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone releasing activity persists in the deafferented medial-basal hypothalamus of the rat.
Antoni FA; Makara GB; Rappay G
J Endocrinol; 1981 Dec; 91(3):415-25. PubMed ID: 6120201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
